Ken Griffin Axogen, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Axogen, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 40,100 shares of AXGN stock, worth $583,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,100

Previous 40,700 1.47%

Holding current value

$583,856

Previous $328,000 11.59%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $453,730 - $644,985	80,023 New	80,023 $579,000
Q4 2023 Feb 14, 2024	SELL	$3.61 - $7.76 $151,728 - $326,152	-42,030 Reduced 55.57%	33,598 $229,000
Q3 2023 Nov 14, 2023	SELL	$4.68 - $9.26 $227,841 - $450,813	-48,684 Reduced 39.16%	75,628 $378,000
Q2 2023 Aug 14, 2023	SELL	$8.5 - $10.38 $849,099 - $1.04 Million	-99,894 Reduced 44.55%	124,312 $1.13 Million
Q1 2023 May 15, 2023	SELL	$7.53 - $10.95 $223,475 - $324,974	-29,678 Reduced 11.69%	224,206 $2.12 Million
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $2.14 Million - $2.97 Million	226,685 Added 833.43%	253,884 $2.53 Million
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $1.49 Million - $2.24 Million	-182,754 Reduced 87.05%	27,199 $325,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $1.44 Million - $2.05 Million	-205,368 Reduced 49.45%	209,953 $1.72 Million
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $692,059 - $1.02 Million	95,325 Added 29.79%	415,321 $3.3 Million
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $1.89 Million - $3.44 Million	215,112 Added 205.1%	319,996 $3 Million
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $375,556 - $535,593	24,659 Added 30.74%	104,884 $1.66 Million
Q2 2021 Aug 16, 2021	SELL	$17.8 - $23.5 $464,152 - $612,786	-26,076 Reduced 24.53%	80,225 $1.73 Million
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $998,982 - $1.31 Million	58,148 Added 120.76%	106,301 $2.15 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $177,134 - $276,637	15,403 Added 47.03%	48,153 $862,000
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $347,805 - $429,680	32,750 New	32,750 $381,000
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $690,157 - $1.02 Million	-93,899 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.38 - $17.34 $935,618 - $1.94 Million	-111,649 Reduced 54.32%	93,899 $976,000
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $1.93 Million - $3.22 Million	172,868 Added 528.97%	205,548 $3.68 Million
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $264,601 - $447,787	21,886 Added 202.76%	32,680 $407,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $989,916 - $1.36 Million	-53,509 Reduced 83.21%	10,794 $214,000
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $580,501 - $878,693	-39,706 Reduced 38.18%	64,303 $0
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $462,831 - $1.04 Million	-27,082 Reduced 20.66%	104,009 $2.12 Million
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $3.36 Million - $5.52 Million	98,752 Added 305.37%	131,091 $0
Q2 2018 Aug 10, 2018	BUY	$36.15 - $52.5 $35,029 - $50,872	969 Added 3.09%	32,339 $0
Q1 2018 May 11, 2018	BUY	$24.4 - $40.25 $765,428 - $1.26 Million	31,370 New	31,370 $1.15 Million
Q4 2017 Feb 09, 2018	SELL	$18.5 - $28.6 $503,773 - $778,806	-27,231 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$14.65 - $19.35 $398,934 - $526,919	27,231	27,231 $527,000

Others Institutions Holding AXGN

# of Institutions

129

Shares Held

35.8M

Call Options Held

79.1K

Put Options Held

500

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $616M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account